Comparison of ESP and QL Blocks for Postoperative Pain in Pediatric Appendectomy (ESP-QLB)
ESP-QLB
Comparative Effects of Erector Spinae Plane and Quadratus Lumborum Blocks on Postoperative Pain and Analgesic Requirement in Pediatric Appendectomy: A Prospective Randomized Controlled Trial
1 other identifier
interventional
60
1 country
2
Brief Summary
This prospective randomized controlled clinical trial aims to compare the analgesic effectiveness of the Erector Spinae Plane (ESP) block and the Quadratus Lumborum (QL) block in pediatric patients undergoing appendectomy. Both regional anesthesia techniques have been shown to reduce opioid requirements and improve postoperative recovery in children; however, there is limited evidence directly comparing their efficacy. In this study, eligible participants will be randomly assigned to receive either an ESP or a QL block in addition to standard general anesthesia before surgical incision. Postoperative outcomes will include pain scores, total opioid consumption, time to first analgesic requirement, mobilization time, parental satisfaction, length of hospital stay, block-related complications and block performance time. The findings are expected to guide clinicians in selecting the most effective regional anesthesia technique for postoperative pain control in pediatric appendectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2025
CompletedStudy Start
First participant enrolled
December 13, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2026
CompletedMay 5, 2026
April 1, 2026
4 months
November 16, 2025
April 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Score
Pain intensity will be evaluated at rest using the Oucher Pain Rating Scale. Higher scores indicate greater pain.
Pain scores will be assessed at 1, 6, 12, and 24 postoperative hours.
Secondary Outcomes (7)
Total Analgesic Consumption
Recorded during the first 24 hours after surgery
Time to First Analgesic Requirement
From the end of surgery until the first documented analgesic requirement, assessed up to 24 hours postoperatively
Time to Mobilization
From the end of surgery until the first successful ambulation with or without assistance, assessed up to 24 hours postoperatively
Length of Hospital Stay
From the end of surgery until hospital discharge, typically within 24-48 hours.
Parents' Postoperative Pain Measure (PPPM)
Assessed at 1, 6, 12, and 24 hours postoperatively
- +2 more secondary outcomes
Study Arms (2)
QLB Block
EXPERIMENTALUltrasound-guided transmuscular QL block using 0.25% bupivacaine (0.5 mL/kg) before surgical incision.
ESP Block
ACTIVE COMPARATORUltrasound-guided ESP block at the L1 level using 0.25% bupivacaine (0.5 mL/kg) before surgical incision.
Interventions
Ultrasound-guided transmuscular QL block performed under general anesthesia using 0.25% bupivacaine (0.5 mL/kg) before surgical incision.
Ultrasound-guided ESP block at the L1 level under general anesthesia using 0.25% bupivacaine (0.5 mL/kg) before surgical incision.
Eligibility Criteria
You may qualify if:
- Patients aged 3-13 years
- Diagnosis of acute appendicitis requiring appendectomy
- ASA physical status I-II
- Planned general anesthesia with intraoperative regional block (ESP or QL block)
- Written informed consent obtained from parents or legal guardians
You may not qualify if:
- Refusal of regional block by family or anesthesia team
- Coagulopathy or anticoagulant medication use
- Local infection at the block injection site
- Known allergy or contraindication to local anesthetics
- Neurological or neuromuscular disorders
- Cognitive impairment preventing postoperative pain assessment
- Conversion to open surgery
- Intraoperative complications requiring deviation from study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zeycan Kahyalead
Study Sites (2)
Kutahya City Hospital Anesthesia and Reanimation Department
Kütahya, Kütahya, 43100, Turkey (Türkiye)
Kutahya City Hospital
Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Süleyman Camgöz
Kutahya Health Sciences University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medicine of Doctor
Study Record Dates
First Submitted
November 16, 2025
First Posted
December 24, 2025
Study Start
December 13, 2025
Primary Completion
April 15, 2026
Study Completion
April 28, 2026
Last Updated
May 5, 2026
Record last verified: 2026-04